share_log

Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144

Teladoc Health | 144：拟议出售证券

美股sec公告 ·  03/04 16:01
Moomoo AI 已提取核心信息
Jason N. Gorevic, an officer and director at Teladoc Health, Inc., is set to sell 53,755 shares of common stock on March 4, 2024, according to a recent filing. The shares, valued at an aggregate market value of $780,286.09, were acquired on March 1, 2024, as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a smaller sale that occurred in the past three months, where Gorevic sold 2,877 shares, resulting in gross proceeds of $54,381.05.
Jason N. Gorevic, an officer and director at Teladoc Health, Inc., is set to sell 53,755 shares of common stock on March 4, 2024, according to a recent filing. The shares, valued at an aggregate market value of $780,286.09, were acquired on March 1, 2024, as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a smaller sale that occurred in the past three months, where Gorevic sold 2,877 shares, resulting in gross proceeds of $54,381.05.
根据最近的一份文件，Teladoc Health, Inc. 的高级管理人员兼董事杰森·戈雷维奇定于2024年3月4日出售53,755股普通股。这些股票的总市值为780,286.09美元，于2024年3月1日作为限制性股票归属的一部分收购，被视为发行人的补偿。该交易是在过去三个月中进行的一次小规模出售之后进行的，戈雷维奇出售了2877股股票，总收益为54,381.05美元。
根据最近的一份文件，Teladoc Health, Inc. 的高级管理人员兼董事杰森·戈雷维奇定于2024年3月4日出售53,755股普通股。这些股票的总市值为780,286.09美元，于2024年3月1日作为限制性股票归属的一部分收购，被视为发行人的补偿。该交易是在过去三个月中进行的一次小规模出售之后进行的，戈雷维奇出售了2877股股票，总收益为54,381.05美元。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息